CBIO vs F · rev $1.0M vs rev $187.27B
Crescent Biopharma, Inc. (CBIO) versus Ford Motor Company (F) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Ford Motor Company (F) is a auto manufacturers company listed on US. It is led by Jim Farley.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
Latest reported F revenue for 2025-12-31 was $187.27B. Net income was -$8.16B. Revenue was up 1.2% from 2024-12-31 to 2025-12-31. F currently screens at market cap $59.37B.
CBIO currently screens at market cap $491.3M. F currently screens at market cap $59.37B.
Not investment advice. Open the CBIO and F stock pages for the full models.
Not investment advice.